Status:
COMPLETED
Narrow-Band UVB-Therapy in Psoriasis
Lead Sponsor:
Radboud University Medical Center
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Study on two different irradiation schemes in UVB phototherapy for psoriasis. Previous studies demonstrated a similar clinical effect in erythematogenic and suberythematogenic irradiation, with less c...
Detailed Description
109 psoriasis patients, referred for UVB phototherapy, participated in our study after given their written informed consent. After determining the minimal erythema dose (MED) patients were randomised ...
Eligibility Criteria
Inclusion
- Eligible for UVB phototherapy
- Older than 18 years
Exclusion
- No topical medication for 2 weeks
- No systemic medication for 4 weeks
- No medication (betablocker, lithium) interfering with psoriasis
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT00748020
Start Date
January 1 2003
End Date
January 1 2007
Last Update
September 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre, Department of Dermatology
Nijmegen, Nijmegen, Netherlands, 6525 GL